140 research outputs found

    Study of prevalence of bacterial vaginosis in preterm and term labour patients

    Get PDF
    Background: Bacterial vaginosis (BV) is a clinical condition caused by replacement of the normal hydrogen peroxide producing Lactobacillus species with high concentrations of aerobic and anaerobic bacteria. Studies have shown that spontaneous abortion, preterm labour (PTL), premature birth, preterm premature rupture of membranes, amniotic fluid infection, and postpartum endometritis are increased because of infection with BV. In India, not many studies have been done to estimate the prevalence and association of BV with preterm labour, hence this study is being taken up to know the prevalence of BV in preterm and term labour patients and its relationship with preterm delivery, low birth weight of baby and puerperal sepsis.The objective of the present study was to observe the prevalence of bacterial vaginosis in women presenting with preterm and term labour, its impact on preterm and term delivery and to analyze the maternal and fetal complications associated with BV.Methods: An observational study involving 100 patients with preterm and term labour (50 patients in each group) was conducted at a BNMCCC, Government Medical College, Amritsar. Women fulfilling the Amsel’s criteria and/or a score of 7 or more on gram staining of vaginal smears (Nugent’s score) was considered to have bacterial vaginosis.Results: The proportion of patients, who fulfilled Amsel’s criteria and/or a Nugent’s score of 7 or more for the diagnosis of BV, was more in PTL group versus term labour group, and the difference was statistically significant. Prevalence of BV in preterm labour and term labour patients was 18(36%) versus 4(8%) respectively. In PTL group, 27.8% of low birth weight neonates were born to BV positive mothers versus 3.1% were born to BV negative mothers. Maternal postpartum complications observed were 33.3% with BV versus 6.25% without BV in PTL group.Conclusions: BV is major risk factor for PTL. Therefore, the testing and prompt treatment of BV may reduce the risk of PTL. This will also go a long way in the prevention of maternal morbidity and neonatal complications due to prematurity

    Major Thrombotic Event Despite Anticoagulation in a Patient With COVID-19.

    Get PDF
    The outbreak of coronavirus disease 2019 (known as COVID-19), which started in Wuhan, China in December 2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has been associated with both venous and arterial thromboembolism likely secondary to significant cytokine activation and inflammation. Reports on the incidence of thrombotic complications, however, are not well documented. Our case will examine a young man diagnosed with COVID-19 who developed an acute, severe bilateral saddle pulmonary embolism while on prophylactic dose anticoagulation after being admitted to the hospital and treated for two weeks with significant improvement

    The advent of system toxicology: aims and aspect of toxicogenomics

    Get PDF
    Last fifty years a significant advancement has been established in biological science. It happened due to the discovery of gene, genome and genetic code, function of genes and mutation of genes. Through this, the scientists have discovered that genetic code is the building block and fundamental of all molecular activity in biological system. According to this, several molecular techniques have been established to prove molecular events, effects of chemical exposure within individuals and environment. For this evaluation, the necessary of toxicogenomics is crucial, that deals with the effects of chemical in changing the genetic pattern along with mutation into gene. Toxicogenomics also deals with transcription of proteins and metabolite profiling to investigate the interaction of genes and environment stress in disease. Toxicogenomics also described the altered expression of genes caused by mutation and chemical exposure that cause several disease and show toxicant functions in cell. The main objective of toxicogenomics is to remove this exposure and provide remedy of these toxical diseases. The use, application, correlation, combination and collaboration of different significant, major, modern biological fields like proteomics, transcriptomics, bioinformatics, microarray and several other molecular process is carried out by toxicogenomics that gradually evolving in systems toxicology. This review recovered the evolution and significant application of the different fields of toxicogenomics
    • …
    corecore